ArticleJournal of medicinal chemistry2022

Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.

Fredrik R Zetterberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.